Imported Intravenous Fluids Face 5% Countervailing Duty Rate

The Tribunal determined that imported Intravenous fluids are subject to a Countervailing Duty (CVD) rate of 5% ad valorem under Notification No. 2/11-C.E. The condition of non-availment of CENVAT credit under Notification No. 1/11-C.E. cannot be met by imported goods, leading to the rejection of the appellant's claim for a concessional 1% rate. The appeals were dismissed, upholding the department's assessment of the 5% CVD rate for the imported goods.

---

---

Issues Involved:
1. Determination of the applicable rate of Countervailing Duty (CVD) on imported Intravenous fluids.
2. Interpretation of conditions stipulated in Notification No. 1/11-C.E. and Notification No. 2/11-C.E.
3. Applicability of the CENVAT credit condition to imported goods.
4. Relevance of judicial precedents and administrative instructions in determining the applicable CVD rate.

Detailed Analysis:

1. Determination of the applicable rate of Countervailing Duty (CVD) on imported Intravenous fluids:
The appellant, M/s. Fresenius Kabi India Pvt. Ltd., imported Intravenous fluids classified under Chapter 30 of the Customs Tariff and claimed a concessional CVD rate of 1% ad valorem under Notification No. 1/11-C.E. The department assessed the goods at a 5% CVD rate under Notification No. 2/11-C.E., leading to the appellant's appeal. The Tribunal held that the applicable CVD rate for the imported Intravenous fluids is 5% ad valorem as per Notification No. 2/11-C.E., rejecting the appellant's claim for the 1% rate.

2. Interpretation of conditions stipulated in Notification No. 1/11-C.E. and Notification No. 2/11-C.E.:
Notification No. 1/11-C.E. prescribes a 1% ad valorem rate for Intravenous fluids, subject to the condition that no CENVAT credit is availed. Notification No. 2/11-C.E. prescribes a 5% ad valorem rate without any conditions. The Tribunal noted that the benefit of the 1% rate is contingent upon the non-availment of CENVAT credit, a condition that cannot be satisfied by imported goods as CENVAT credit rules apply only to domestic manufacturers.

3. Applicability of the CENVAT credit condition to imported goods:
The Tribunal emphasized that the condition of non-availment of CENVAT credit under Notification No. 1/11-C.E. cannot be met by imported goods, as the CENVAT Credit Rules, 2004, apply solely to manufacturers in India. Consequently, the imported goods are ineligible for the 1% concessional rate, and the highest rate of 5% ad valorem under Notification No. 2/11-C.E. must be applied.

4. Relevance of judicial precedents and administrative instructions in determining the applicable CVD rate:
The Tribunal referred to several judicial precedents, including the Supreme Court's decisions in Thermax Pvt. Ltd. v. Collector of Customs and Malwa Industries Ltd., and the Larger Bench decision in Priyesh Chemicals & Metals v. Commissioner of Central Excise. It was noted that the imported goods must satisfy both the description and the conditions of the exemption notification to avail the concessional rate. The Tribunal also considered the C.B.E. & C. Circular B-1/3/2011-TRU, which clarified that the 1% rate under Notification No. 1/11-C.E. does not apply to imported goods for CVD purposes, reinforcing the decision to apply the 5% rate.

Conclusion:
The Tribunal concluded that the imported Intravenous fluids are subject to a CVD rate of 5% ad valorem under Notification No. 2/11-C.E., as the condition of non-availment of CENVAT credit under Notification No. 1/11-C.E. cannot be fulfilled by imported goods. The appeals were dismissed, affirming the department's assessment.

---